StockTipsArenaBeta

BUY Jagsonpal Pharmaceuticals Limited — Sudeep Shah, SBICAP Securities

BUYJagsonpal Pharmaceuticals Limited

bySudeep Shah, SBICAP SecuritiesHorizon: 1–3 months18 Aug 2026via Zee Business (Live)

Entry₹234Inferred
Target₹255
Total upside +8.97%
Stop loss₹225-3.85% risk
CMP₹237.72Just now
Active+1.59%+7.27%upside left 2 mo left
Follow Sudeep Shah for new calls(38% target hit, 21 closed calls)Get alertsWatch JAGSNPHARM for new buy/sell callsGet alertsSee 28 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 4:13 pm IST
3 supporting2 neutral0 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·8 Sept · today

Jagsonpal Q1 Results: Net profit rises to ₹84.3 lakh, revenue up 44%

NewsGoogle News·12 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.